Dual antiplatelet therapy duration in patients following percutaneous coronary intervention or after acute coronary syndrome: one size does not fit all

Future Cardiol. 2017 May;13(3):199-201. doi: 10.2217/fca-2017-0017. Epub 2017 May 31.
No abstract available

Keywords: acute coronary syndromes; antiplatelet agents; ischemic heart disease; percutaneous coronary interventions.

Publication types

  • Editorial

MeSH terms

  • Acute Coronary Syndrome / therapy*
  • Coronary Restenosis / prevention & control*
  • Drug Therapy, Combination
  • Humans
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Postoperative Care / methods*

Substances

  • Platelet Aggregation Inhibitors